CoChat

Prevention of Adrenal Crisis: Cortisol Responses to Major Stress Compared to Stress Dose Hydrocortisone Delivery

Open access

Published version of a preprint

The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index; 9 of the 27 sources its claims cite were checked for support.

Abstract

Context: Patients with adrenal insufficiency require increased hydrocortisone cover during major stress to avoid a life-threatening adrenal crisis. However, current treatment recommendations are not evidence-based. Objective: To identify the most appropriate mode of hydrocortisone delivery in patients with adrenal insufficiency who are exposed to major stress. Design and Participants: Cross-sectional study: 122 unstressed healthy subjects and 288 subjects exposed to different stressors (major trauma [N = 83], sepsis [N = 100], and combat stress [N = 105]). Longitudinal study: 22 patients with preserved adrenal function undergoing elective surgery. Pharmacokinetic study: 10 patients with primary adrenal insufficiency undergoing administration of 200 mg hydrocortisone over 24 hours in 4 different delivery modes (continuous intravenous infusion; 6-hourly oral, intramuscular or intravenous bolus administration). Main Outcome Measure: We measured total serum cortisol and cortisone, free serum cortisol, and urinary glucocorticoid metabolite excretion by mass spectrometry. Linear pharmacokinetic modeling was used to determine the most appropriate mode and dose of hydrocortisone administration in patients with adrenal insufficiency exposed to major stress. Results: Serum cortisol was increased in all stress conditions, with the highest values observed in surgery and sepsis. Continuous intravenous hydrocortisone was the only administration mode persistently achieving median cortisol concentrations in the range observed during major stress. Linear pharmacokinetic modeling identified continuous intravenous infusion of 200 mg hydrocortisone over 24 hours, preceded by an initial bolus of 50–100 mg hydrocortisone, as best suited for maintaining cortisol concentrations in the required range. Conclusions: Continuous intravenous hydrocortisone infusion should be favored over intermittent bolus administration in the prevention and treatment of adrenal crisis during major stress.

Overview

CoChat Summary

TL;DR

In patients with adrenal insufficiency, continuous intravenous hydrocortisone was the only delivery mode that persistently maintained serum cortisol in the range seen during major stress, whereas intermittent bolus dosing produced peaks and troughs. Pharmacokinetic modeling identified continuous intravenous infusion of 200 mg hydrocortisone over 24 hours, preceded by an initial 50–100 mg intravenous bolus, as the best-suited regimen.

Key findings

  • Serum total cortisol was increased in all stress conditions, with the highest and most variable concentrations in sepsis, followed by elective surgery, combat stress, and major trauma; pairwise comparisons were significant between unstressed controls and all stressed groups except major trauma.
  • Continuous intravenous hydrocortisone was the only administration mode persistently achieving median cortisol concentrations in the range observed during major stress; bolus modes (oral, intramuscular, intravenous) produced Cmax values of 1423, 1152, and 1449 nmol/L and Cmin values of 277, 289, and 171 nmol/L, respectively, while continuous intravenous infusion had Cmax 836 nmol/L and Cmin 520 nmol/L.
  • Linear pharmacokinetic modeling identified continuous intravenous infusion of 200 mg hydrocortisone over 24 hours, preceded by an initial bolus of 50–100 mg hydrocortisone, as best suited for maintaining cortisol concentrations in the required range.
  • Free serum cortisol at Tmax after all four hydrocortisone regimens was significantly higher than in stress conditions except sepsis, where it tended to be higher; during continuous intravenous infusion at Tmin, free cortisol was significantly higher than in surgical patients at knife-to-skin and 4 hours into surgery and after acute trauma, but significantly lower than in sepsis.

Methods

  • Cross-sectional study: 122 unstressed healthy controls and 288 stressed subjects (major trauma N = 83, sepsis N = 100, combat stress N = 105).
  • Longitudinal study: 22 patients with preserved adrenal function undergoing elective surgery with repeated serum sampling over 24 hours.
  • Pharmacokinetic study: randomized, open-label study in 10 patients with primary adrenal insufficiency receiving 200 mg hydrocortisone over 24 hours by four modes (continuous intravenous infusion; 6-hourly oral, intramuscular, or intravenous bolus). Total serum cortisol and cortisone, free serum cortisol, and urinary glucocorticoid metabolites were measured by mass spectrometry; linear pharmacokinetic modeling used mixed-effects analysis.

Limitations

  • The paper states that serum cortisol was measured repeatedly over 24 hours only during elective surgery, while other stress conditions were measured at a single time point; it also states that cortisol metabolism dynamics during surgery and major stress were not assessed, and that reduced cortisol clearance during critical illness may affect hydrocortisone requirements.
  • The paper states that the surgical group comprised mostly patients undergoing moderately invasive procedures, so more invasive or longer-lasting surgeries could yield higher cortisol concentrations; mineralocorticoid activity of the four regimens could not be analyzed.
  • Evident from the text: the pharmacokinetic study included only 10 patients with primary adrenal insufficiency, limiting precision for modeled dose recommendations.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1210/clinem/dgaa133

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1. Summary of the studies performed. Assessment of the circulating and urinary glucocorticoid concentrations in response to different stress conditions and to stress dose hydrocortisone administration. Abbreviations: IM, intramuscular injection; IVI, intravenous injection; CIV, continuous intravenous infusion.
Figure 1. Summary of the studies performed. Assessment of the circulating and urinary glucocorticoid concentrations in response to different stress conditions and to stress dose hydrocortisone administration. Abbreviations: IM, intramuscular injection; IVI, intravenous injection; CIV, continuous intravenous infusion.CC BY · PubMed Central
Figure 2. Circulating glucocorticoids during major stress. Serum concentrations of total cortisol (nmol/L) (a), total cortisone (nmol/L) (b), and cortisol (F)/cortisone (E) ratio (c) in healthy controls (N = 122), during combat stress (N = 105), during elective surgery (N = 22), after major trauma (N = 83), and during sepsis (N = 100). In the patients undergoing elective surgery, the maximum serum cortisol levels (and corresponding serum cortisone levels) were used for the calculations. Panel d: reports serum free cortisol concentrations in nmol/L in healthy controls (N = 11), during elective surgery at knife-to-skin (KTS, N = 21), and 4 hours after the start of the operation (N = 21), after major trauma (N = 18), and during sepsis (N = 17). Panel e: reports the 24-hour urinary excretion of cortisol, cortisol metabolites, cortisone, and cortisone metabolites in healthy controls (N = 122), following elective surgery (N = 21) and after major trauma (N = 23). Boxes show median and interquartile range, whiskers are 5th to 95th percentile. Symbols: n.s., P > 0.05; *, P ≤ 0.05; **, P ≤ 0.01; ***, P ≤ 0.001.
Figure 2. Circulating glucocorticoids during major stress. Serum concentrations of total cortisol (nmol/L) (a), total cortisone (nmol/L) (b), and cortisol (F)/cortisone (E) ratio (c) in healthy controls (N = 122), during combat stress (N = 105), during elective surgery (N = 22), after major trauma (N = 83), and during sepsis (N = 100). In the patients undergoing elective surgery, the maximum serum cortisol levels (and corresponding serum cortisone levels) were used for the calculations. Panel d: reports serum free cortisol concentrations in nmol/L in healthy controls (N = 11), during elective surgery at knife-to-skin (KTS, N = 21), and 4 hours after the start of the operation (N = 21), after major trauma (N = 18), and during sepsis (N = 17). Panel e: reports the 24-hour urinary excretion of cortisol, cortisol metabolites, cortisone, and cortisone metabolites in healthy controls (N = 122), following elective surgery (N = 21) and after major trauma (N = 23). Boxes show median and interquartile range, whiskers are 5th to 95th percentile. Symbols: n.s., P > 0.05; *, P ≤ 0.05; **, P ≤ 0.01; ***, P ≤ 0.001.CC BY · PubMed Central
Figure 3. Serum total cortisol following hydrocortisone administration. Serum total cortisol (nmol/L) in 10 patients with adrenal insufficiency after hydrocortisone administered ORAL, IM, as IVI, and as CIV. Data are presented as median (black line) and range (shaded grey area).
Figure 3. Serum total cortisol following hydrocortisone administration. Serum total cortisol (nmol/L) in 10 patients with adrenal insufficiency after hydrocortisone administered ORAL, IM, as IVI, and as CIV. Data are presented as median (black line) and range (shaded grey area).CC BY · PubMed Central
Figure 4. Comparison of serum total cortisol during elective surgery of longer duration and following hydrocortisone administration. Serum total cortisol concentrations (nmol/L) in 10 patients with adrenal insufficiency after the administration of 50 mg hydrocortisone over 6 hours (black line: median, whiskers: range) in 4 different modes (ORAL, IM or IVI, or as CIV) projected onto serum cortisol concentrations observed in patients undergoing elective surgery (panels a–d, serum cortisol in 11 patients undergoing elective surgery of longer duration [red line: median; red shaded area: range]; panels e–h, serum cortisol in 11 patients undergoing elective surgery of shorter duration [blue line: median; blue shaded area: range]) from time point knife-to-skin (KTS; 0 hours) to 6 hours post-KTS. All measurements were carried out by tandem mass spectrometry.
Figure 4. Comparison of serum total cortisol during elective surgery of longer duration and following hydrocortisone administration. Serum total cortisol concentrations (nmol/L) in 10 patients with adrenal insufficiency after the administration of 50 mg hydrocortisone over 6 hours (black line: median, whiskers: range) in 4 different modes (ORAL, IM or IVI, or as CIV) projected onto serum cortisol concentrations observed in patients undergoing elective surgery (panels a–d, serum cortisol in 11 patients undergoing elective surgery of longer duration [red line: median; red shaded area: range]; panels e–h, serum cortisol in 11 patients undergoing elective surgery of shorter duration [blue line: median; blue shaded area: range]) from time point knife-to-skin (KTS; 0 hours) to 6 hours post-KTS. All measurements were carried out by tandem mass spectrometry.CC BY · PubMed Central
Figure 5. Linear pharmacokinetic modeling of stress dose hydrocortisone administration. Mixed effects linear pharmacokinetic modeling of serum cortisol in response to intravenous hydrocortisone administration modes. Serum cortisol concentrations are presented in nmol/L; the black lines show the fixed effect (central tendency) kinetics, the shaded gray area indicates 90% of between-patient variability. Panels a and b: show cortisol measurements (circles) following 50 mg IV bolus injection and the fitted model over 6 and 24 hours, respectively. The pharmacokinetic modeling was also used to predict the serum cortisol response to 100 mg IV bolus injection over 6 and 24 hours (panels c and d, respectively), as well as initial 50 mg (panel e) and 100 mg (panel f) IV bolus injections followed by CIV infusion of 200 mg per 24-hour hydrocortisone.
Figure 5. Linear pharmacokinetic modeling of stress dose hydrocortisone administration. Mixed effects linear pharmacokinetic modeling of serum cortisol in response to intravenous hydrocortisone administration modes. Serum cortisol concentrations are presented in nmol/L; the black lines show the fixed effect (central tendency) kinetics, the shaded gray area indicates 90% of between-patient variability. Panels a and b: show cortisol measurements (circles) following 50 mg IV bolus injection and the fitted model over 6 and 24 hours, respectively. The pharmacokinetic modeling was also used to predict the serum cortisol response to 100 mg IV bolus injection over 6 and 24 hours (panels c and d, respectively), as well as initial 50 mg (panel e) and 100 mg (panel f) IV bolus injections followed by CIV infusion of 200 mg per 24-hour hydrocortisone.CC BY · PubMed Central

Verification

Claims the paper makes

8 Valid · 0 Not valid · 16 Not checked · 56 Own results and interpretations

46 more claims

Create a free account to see all 80 claims and to verify the 18 references still open.

See all claims — free account
  • It may state two separate claims as one. 22
  • Probably not a substantial claim. 11

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

2 of 2

Citations

Cites

Show all 35 references

Cited by

See all 96

Metadata

Authors
Prete, A., Taylor, A. E., Bancos, I., Smith, D. J., Foster, M. A., Kohler, S., Fazal-Sanderson, V., Komninos, J., O’Neil, D. M., Vassiliadi, D. A., Mowatt, C. J., Mihai, R., Fallowfield, J. L., Annane, D., Lord, J. M., Keevil, B. G., Wass, J. A. H., Karavitaki, N., & Arlt, W.
Affiliations
  • University of Birmingham (GB)
  • Mayo Clinic (US)
  • Queen Elizabeth Hospital Birmingham (GB)
  • Oxford Centre for Diabetes, Endocrinology and Metabolism, Churchill Hospital, Oxford, UK
  • Churchill Hospital (GB)
  • Evangelismos Hospital (GR)
  • Royal Shrewsbury Hospital (GB)
  • Royal Navy (GB)
  • Inserm (FR)
  • University Hospitals Birmingham NHS Foundation Trust (GB)
  • Manchester Academic Health Science Centre (GB)
Corresponding author
Arlt, Wiebke
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
2020-03-14
Volume
105
Issue
7
Pages
2262-2274
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W3011408494
Cited by
96
References
35
Citations by year
2026: 5 · 2025: 7 · 2024: 12 · 2023: 14 · 2022: 20 · 2021: 22 · 2020: 16
FWCI
13.58
Type
journal article
Language
en
Open access
Locations
  • The Journal of Clinical Endocrinology & Metabolism (publishedVersion, cc-by)
  • medRxiv (acceptedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • HAL (submittedVersion, cc-by)
  • University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
  • University of Birmingham Research Portal (University of Birmingham) (submittedVersion, cc-by)
  • University of Birmingham Research Portal (University of Birmingham) (submittedVersion, other-oa)
Funders
  • University Hospitals Birmingham NHS Foundation Trust and the University of Birmingham (BRC-1215–2009)
  • Diabetes UK Sir George Alberti Research Training Fellow (18/0005782)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
  • Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
Keywords
adrenal crisis, adrenal insufficiency, cortisol, continuous intravenous infusion, bolus administration, pharmacokinetics, sepsis, trauma (physical injury), combat stress, glucocorticoid metabolites
MeSH terms
Administration, Oral, Adolescent, Adrenal Insufficiency, Adult, Aged, Aged, 80 and over, Cortisone, Cross-Sectional Studies, Drug Administration Schedule, Female, Glucocorticoids, Humans, Hydrocortisone, Infusions, Intravenous, Male, Middle Aged, Mass Spectrometry, Stress, Physiological, Stress, Psychological, Treatment Outcome, Sepsis, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-07, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-07 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (qwen3.8-omni-flash and gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Prevention of Adrenal Crisis: Cortisol Responses to Major Stress Compared to Stress Dose Hydrocortisone Delivery. https://app.cochat.ai/papers/10.1210/clinem/dgaa133
The paper
Prete, A., Taylor, A. E., Bancos, I., Smith, D. J., Foster, M. A., Kohler, S., Fazal-Sanderson, V., Komninos, J., O’Neil, D. M., Vassiliadi, D. A., Mowatt, C. J., Mihai, R., Fallowfield, J. L., Annane, D., Lord, J. M., Keevil, B. G., Wass, J. A. H., Karavitaki, N., & Arlt, W. (2020). Prevention of Adrenal Crisis: Cortisol Responses to Major Stress Compared to Stress Dose Hydrocortisone Delivery. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgaa133

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.